TearLab Corporation to Release Q3 2013 Financial Results on November 12, 2013
21 Octobre 2013 - 11:30PM
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its
Q3 2013 financial results after market closes on Tuesday November
12, 2013. TearLab is pleased to invite all willing participants in
a conference call during which time financial results will be
discussed. This call will be held at 4:30pm Eastern at
877-303-1593.
Date: November 12, 2013
Time: 4:30 PM ET
Listen via Internet: http://www.tearlab.com/investor/
Schedule this webcast into MS-Outlook calendar (click open when
prompted):
http://apps.shareholder.com/PNWOutlook/t.aspx?m=61778&k=75D0A86B
Telephone: 877-303-1593
For those wishing to listen to a recording of the call via
telephone, a replay will be made available by 7:30pm Eastern after
the conclusion of the live call and will remain posted until
11:59pm Eastern on November 19, 2013. To listen to the recording,
simply telephone 855-859-2056 (toll free) or 404-537-3406 and enter
conference ID:90315243 when prompted.
About TearLab Corporation
TearLab Corporation (www.tearlab.com) develops and
commercializes lab-on-a-chip technologies that enable eye care
practitioners to improve standard of care by objectively and
quantitatively testing for disease markers in tears at the
point-of-care. The TearLab(r) Osmolarity Test, that enables eye
care practitioners to test for highly sensitive and specific
biomarkers using nanoliters of tear film at the point-of-care, is
the first assay developed for the award winning TearLab Osmolarity
System. Headquartered in San Diego, CA, TearLab Corporation's
common shares trade on the NASDAQ Capital Market under the symbol
'TEAR' and on the Toronto Stock Exchange under the symbol
'TLB'.
Forward-Looking Statements This press release may contain
forward-looking statements. These statements relate to future
events and are subject to risks, uncertainties and assumptions
about TearLab. Examples of forward-looking statements in this press
release include statements regarding the future potential of the
TearLab Osmolarity System and the related impact on our sales.
These statements are only predictions based on our current
expectations and projections about future events. You should not
place undue reliance on these statements. Actual events or results
may differ materially. Many factors may cause our actual results to
differ materially from any forward-looking statement, including the
factors detailed in our filings with the Securities and Exchange
Commission and Canadian securities regulatory authorities,
including but not limited to our annual and quarterly reports on
Forms 10-K and 10-Q. We do not undertake to update any
forward-looking statements.
CONTACT: Kilmer Lucas Inc.
Stephen Kilmer (President)
905 906 6908
stephen@kilmerlucas.com
Kilmer Lucas Inc.
Leonard Zehr (Managing Director)
905 690 2400 Ext.41
len@kilmerlucas.com
Talbots (NYSE:TLB)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Talbots (NYSE:TLB)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
Real-Time news about Talbots (The) (New York Stock Exchange): 0 recent articles
Plus d'articles sur